Dr. Thomas Wade Debeck

M.D. | Neurology


  2280 Hemby Ln, Greenville
     North Carolina, 27834-3773
  252-752-4848    252-752-9607 Maps & Directions
Dr. Thomas Wade Debeck is a Greenville, North Carolina based neurologist who is specialized in Neurology. His current practice location is 2280 Hemby Ln, Greenville. Patients can reach him at 252-752-4848 or can fax him at 252-752-9607. Dr. Thomas Wade Debeck is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1396830600.
Dr. Thomas Wade Debeck specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Thomas Wade Debeck speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Thomas Wade Debeck
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:2280 Hemby Ln, Greenville,
North Carolina, 27834-3773
Phone:252-752-4848
Fax:252-752-9607
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1396830600
NPI Enumeration Date: 03 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Thomas Wade Debeck
2280 Hemby Ln,
Greenville, North Carolina
Zip: 27834-3773
Phone Number: 252-752-4848
Fax Number: 252-752-9607
Patients can reach Dr. Thomas Wade Debeck at 2280 Hemby Ln, Greenville, North Carolina or can call to book an appointment on 252-752-4848.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.